Recently published by the Kenya Ministry of Health, this video and accompanying report highlight ongoing progress and reflections from Kenya’s AHD response, including the significance of integrated approaches to HIV care.

The THRIVE UP-ART study is a sub-study of the Uganda Paediatric and Adolescent HIV Cohort on Antiretroviral Therapy (UP-ART), a long-standing observational cohort study capturing data on children and adolescents receiving HIV care across Uganda. Under the THRIVE sub-study, we are working closely with the MOH and the UP-ART team to strengthen both the quality and use of routine care data, better understanding the current gaps in AHD screening and management to support improvem

Service Quality Assessments (SQAs) are indispensable tools for programs aiming to deliver such care, providing the data needed to identify strengths, weaknesses, and areas for improvement. Zimbabwe's experience with conducting SQAs for pediatric AHD services, building upon CHAI’s 2022 Pediatric AHD Landscape Assessment, offers a compelling case study.

Zimbabwe's THRIVE project provides valuable insights into how strategically integrating the comprehensive STOP AIDS training package within DSD models can enhance AHD service delivery.

THRIVE-Zimbabwe aims to evaluate the STOP-AIDS package across an entire rural Zimbabwean district of Shurugwi. The project seeks to identify and overcome barriers to ​its ​implementation at the community and primary care levels.

Nigeria adapted the WHO package of care for Advanced HIV Disease (AHD) in 2020. The package includes CD4 + cell count testing to identify People Living with HIV (PLHIV) with AHD, screening and treatment of opportunistic infections, rapid antiretrovirals (ART) initiation, and intensive adherence follow-up. The national program adopted a phased approach in the rollout of the AHD package of care to learn lessons from a few representative health facilities before scaling up acros

In 2015, Alere, now Abbott, introduced a commercial instrument free Tuberculosis (TB) lipoarabinomannan (LAM) lateral flow assay test (TB...

Partners working on HIV care and treatment across Low- and Middle-Income Countries (LMICs) in Africa identified the development of an...